---
abstract: A considerable proportion of estrogen receptor ER -positive breast cancer
  recurs despite tamoxifen treatment, which is a serious problem commonly encountered
  in clinical practice. We tried to find novel prognostic markers in this subtype
  of breast cancer.
authors: Han W, Han MR, Kang JJ, Bae JY, Lee JH, Bae YJ, Lee JE, Shin HJ, Hwang KT,
  Hwang SE, Kim SW and Noh DY.
contact:
  email: dynoh@plaza.snu.ac.kr
  name: Dong-Youg Noh
counts:
  biosamples: 28
  samples_acgh: 28
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:16608533
geo_data:
  geo_json:
    coordinates:
    - 126.98
    - 37.57
    type: Point
  info:
    city: Seoul
    continent: Asia
    country: Korean Republic
    label: Seoul, Korean Republic, Asia
    precision: city
journal: 'BMC Cancer 6 (2006): 92.'
label: 'Han et al. (2006): Genomic Alterations Identified By Array Comparative Genomic
  Hybridization as Prognostic Markers in ...'
notes: ~
pmid: 16608533
title: Genomic Alterations Identified By Array Comparative Genomic Hybridization as
  Prognostic Markers in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer.
year: 2006
